Autoantibodies to proliferating cell nuclear antigen (PCNA) are specifically, if rarely, present in systemic lupus erythematosus (SLE) patient sera. Even SLE patients lacking PCNA reactivity often show reaction to PCNA-binding protein. Here, immunoreactivity to chromatin assembly factor-1 (CAF-1), an essential molecule for DNA replication and a PCNA-binding protein, was compared for the sera of SLE patients, normal healthy controls (NHCs) and other disease controls, and in autoimmune sera reactive to standard autoantigens, by enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence, and immunoblotting. CAF1 and IRF1 expression in SLE and NHC peripheral mononuclear cells were compared by quantitative real-time polymerase chain reaction. Serum interferon-γ-inducing protein-10 and anti-double-stranded (ds)DNA antibody levels were measured by ELISA. Increased CAF-1 autoimmune reactivity was recognized in SLE or serum anti-dsDNA antibody-positive patients. Significantly greater central nervous system (CNS) involvement (aseptic meningitis) and serum anti-dsDNA antibody titers were present more often in anti-CAF-1 antibody-positive than antibody-negative SLE patients. IFN-γ positively regulated CAF-1 expression in vitro and was associated with anti-CAF-1 antibody production in SLE. Thus, a novel anti-CAF-1 autoantibody is frequently found in patients with SLE and is a useful biomarker for diagnosis, especially in cases with CNS involvement. Aberrant IFN-γ regulation appears to play an important role in anti-CAF-1 antibody production in SLE.
TakasakiYFishwildDTanEM. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med1984; 159: 981–992.
2.
OgataKOgataYTakasakiYTanEM. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J Immunol1987; 139: 2942–2946.
3.
TakasakiYDengJSTanEM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med1981; 154: 1899–1909.
4.
BravoRFrankRBlundellPAMacdonald-BravoH. Cyclin PCNA is the auxiliary protein of DNA polymerase-delta. Nature1987; 326: 515–517.
5.
PrelichGKosturaMMarshakDRMathewsMBStillmanB. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 replication in vitro. Nature1987; 326: 471–475.
6.
NicholsAFSancarA. Purification of PCNA as a nucleotide excision repair protein. Nucl Acids Res1992; 20: 2441–2446.
7.
ShivjiKKKennyMKWoodRD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell1992; 69: 367–374.
8.
ShivjiMKKPodustVNHubscherUWoodRD. Nucleotide excision-repair DNA-synthesis by DNA polymerase-epsilon in the presence of PCNA, RFC, and RPA. Biochemistry1995; 34: 5011–5017.
9.
ChuangLSHIanHIKohTWNgHHXuGLLiBFL. Human DNA (cytosine-5) methyltransferase PCNA complex as a target for p21 (WAF1). Science1997; 277: 1996–2000.
10.
ShibaharaKStillmanB. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin. Cell1999; 96: 575–585.
11.
ChenITSmithMLOconnorPMFornaceAJ. Direct interaction of GADD45 with PCNA and evidence for competitive interaction of GADD45 and P2L (WAF1/CIP1) with PCNA. Oncogene1995; 11: 1931–1937.
12.
GraningerWBHassfeldWPesauBBMacholdKPZielinskiCCSmolenJS. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol1991; 18: 1621–1622.
13.
MiyachiKFritzlerMJTanEM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol1978; 121: 2228–2234.
14.
TakasakiYKanedaKMatsushitaM. Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients. Int Immunol2004; 16: 1295–1304.
15.
KanedaKTakasakiYTakeuchiK. Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases. J Rheumatol2004; 31: 2142–2150.
16.
TakasakiYOhgakiMKodamaA. A sandwich type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA)/cyclin using monoclonal antibodies. J Immunol Methods1990; 132: 227–237.
17.
TakasakiYKogureTTakeuchiK. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol2001; 166: 4780–4787.
18.
KogureTTakasakiYTakeuchiK. Autoimmune responses to proliferating cell nuclear antigen multiprotein complexes involved in cell proliferation are strongly associated with their structure and biologic function in patients with systemic lupus erythematosus. Arthritis Rheum2002; 46: 2946–2956.
19.
SmithSStillmanB. Immunological characterization of chromatin assembly factor-1, a human cell factor required for chromatin assembly during DNA replication in vitro. J Biol Chem1991; 266: 12041–12047.
20.
KrawitzDCKamaTKaufmanPD. Chromatin assembly factor I mutants defective for PCNA binding require Asf1/Hir proteins for silencing. Mol Cell Biol2002; 22: 614–625.
21.
MoggsJGGrandiPQuivyJP. A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA damage. Mol Cell Biol2000; 20: 1206–1218.
22.
KaufmanPDKobayashiRKesslerNStillmanB. The p150 and p60 subunits of chromatin assembly factor-1 – A molecular link between newly synthesized histones and DNA replication. Cell1995; 81: 1105–1114.
23.
MoggsJGAlmouzniG. Chromatin rearrangements during nucleotide excision repair. Biochimie1999; 81: 45–52.
24.
VitaliCBombardieriSJonssonR. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American‐European Consensus Group. Ann Rheum Dis2002; 61: 554–558.
25.
ArnettFCEdworthySMBlochDA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988; 31: 315–324.
26.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
27.
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum1980; 23: 581–590.
28.
AlarconsegoviaDCardielMH. Comparison between 3 diagnostic criteria for mixed connective tissue disease – study of 593 patients. J Rheumatol1989; 16: 328–334.
29.
BohanAPeterJB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med1975; 292: 344–347.
30.
ACR AD Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum1999; 42: 599–608.
31.
NozawaKIkedaKSatohM. Autoantibody to NA14 is an independent marker primarily for Sjögren's syndrome. Front Biosci2009; 14: 3733–3739.
32.
HlinkovaVXingGBauerJ. Structures of monomeric, dimeric and trimeric PCNA: PCNA-ring assembly and opening. Acta Crystallogr D Biol Crystallogr2008; 64: 941–949.
33.
TchenioTCasellaJFHeidmannT. A truncated form of the human CAF-1 p150 subunit impairs the maintenance of transcriptional gene silencing in mammalian cells. Mol Cell Biol2001; 21: 1953–1961.
34.
NozawaKFritzlerMJIkedaKTakasakiYSatohMChanEKL. Differential anti-Golgi complex autoantibody production following murine lactate dehydrogenase-elevating virus infection. Immunopharmacol Immunotoxicol2008; 30: 13–25.
35.
OuraRArakakiRYamadaA. Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages. J Immunol2013; 190: 578–585.
36.
Deobagkar-LeleMChackoSKVictorES. Interferon-γ- and glucocorticoid-mediated pathways synergize to enhance death of CD4(+) CD8(+) thymocytes during Salmonella enterica serovar Typhimurium infection. Immunology2013; 138: 307–321.
37.
XuXYiHGuoZ. Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-γ and nitric oxide. J Immunol2012; 188: 1168–1177.
38.
ZhangZGShibaharaKStillmanB. PCNA connects DNA replication to epigenetic inheritance in yeast. Nature2000; 408: 221–225.
39.
LakePMitchisonNA. Associative control of the immune response to cell surface antigens. Immunol Commun1976; 5: 795–805.
40.
SvenungssonEAnderssonMBrundinL. Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis2001; 60: 372–379.
41.
Fragoso-LoyoHRichaud-PatinYOrozco-NarvaezA. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum2007; 56: 1242–11250.
42.
LuXYZhuCQQianJChenXXYeSGuYY. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lupus2010; 19: 689–695.
43.
OkamotoHIikuniNKamitsujiSYoshioTMinotaSKamataniN. IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients. Rheumatology2006; 45: 232–234.
44.
SanterDMYoshioTMinotaSMollerTElkonKB. Potent Induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol2009; 182: 1192–1201.
45.
HarigaiMKawamotoMHaraMKubotaTKamataniNMiyasakaN. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol2008; 181: 2211–2219.
46.
YanabaKBouazizJDMatsushitaTTsubataTTedderTF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol2009; 182: 7459–7472.
47.
KuroiwaTLeeEG. Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus1998; 7: 597–603.
48.
CarrollJMCromptonTSeeryJPWattFM. Transgenic mice expression IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol1997; 108: 412–422.
49.
SeeryJPWangECYCattellVCarrollJMOwenMJWattFM. A central role for alpha/beta T cells in the pathogenesis of murine lupus. J Immunol1999; 162: 7241–7248.
50.
SchroderKHertzogPJRavasiTHumeDA. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol2004; 75: 163–189.
51.
SahaBPrasannaSJChandrasekarBNandiD. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine2010; 50: 1–14.
52.
TaniguchiTLamphierMSTanakaN. IRF-1: The transcription factor linking the interferon response and oncogenesis. Biochim Biophys Acta1997; 1333: M9–7.
53.
TamuraTIshiharaMLamphierMS. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. Leukemia1997; 11(Suppl 3): 439–440.
54.
NovelliFBernabeiPOzmenL. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J Immunol1996; 157: 1935–1943.
55.
BernabeiPAllioneARigamontiL. Regulation of interferon-gamma receptor (IFN-gamma R) chains: A peculiar way to rule the life and death of human lymphocytes. Eur Cytokine Netw2001; 12: 6–14.
